
Presentation of case: patient 36 years old, appealed to complaints about changing the color of the skin, reducing body weight by 10 kg in 2 months, expressed general weakness, lowering blood pressure, reducing sexual desire. Discussion: prescribed treatment: insulin therapy (aspart, degludec) day dose 42 OD, levothyroxine 100 mcgr/day, vitamin E, selenium 100 mcgr, chorionic gonadotrophin 1500 OD intramuscularly once per week, monthly courses with the same break. After the therapy, the patient’s condition improved. Repeatedly the patient appeared on the review 6 months after treatment. Hyperpigmentation of the skin and natural areas of pigmentation are reduced, there is a stabilization of blood pressure at a level of 120 / 70-110 / 70 mm Hg, reduction of clinical symptoms, achieved target level of glycemia and hormonal blood parameters the target glycemia level was reached (4.6-5.1 mmol / L), glycosylated hemoglobin (8.1%) and hormonal blood parameters (TTG 3.4 mmol / L) cortisol serum 1.7 μg / dl (norm 6.2-19.4 μg / dl), testosterone free 3.4 pg / ml (N 1.7-8.2), total testosterone - 12.28 (N 8.64 - 29 nmol / l), sex steroid binding globulin (CHD) (67 nmol / l, at the rate of 13-71 nmol / l, ), testosterone free 8.9 pg / ml (N 8.8 - 42.5 pg / ml). Conclusions: Decomposition of adrenal insufficiency (decrease in glucocorticoids as contrinsular hormone) can lead to untypical cours of diabetes with steaolyhipoglicemia in autumne-summer period and normalizabionglycemia glycemia in winter-autumne period. Presents of 2-3 decompensate, endocrine diseases in the same moment suppresses pronounced typical symptomatics each of them precedes with erased or disguised picture. Bangladesh Journal of Medical Science Vol.18(3) 2019 p.646-650
diabetes mellitus type 1, autoimmune poluglandular syndrome, первинний гіпогонадизм, первичный гипогонадизм, 610, primary hypogonadism, сахарный диабет типа 1, синдром Карпентера, цукровий діабет типу 1, аутоиммунный полигландулярный синдром, Carpenter syndrome, аутоімунний полігландулярний синдром
diabetes mellitus type 1, autoimmune poluglandular syndrome, первинний гіпогонадизм, первичный гипогонадизм, 610, primary hypogonadism, сахарный диабет типа 1, синдром Карпентера, цукровий діабет типу 1, аутоиммунный полигландулярный синдром, Carpenter syndrome, аутоімунний полігландулярний синдром
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
